FSRH CEU Statement on Nexplanon® Insertion Site 15 January 2020

27a9652c622c47264b59000a7c52fd4e

Published on: 15 January 2020

File size: 327kb PDF

File type: Clinical Statements

This CEU Statement provides guidance to healthcare professionals in response to a letter circulated by MSD (manufacturer of Nexplanon®) to healthcare professionals in the UK about updated guidance regarding the recommended Nexplanon® insertion site.

Your download should start automatically. If not download directly.

Privacy notice

FSRH CEU Statement on Nexplanon® Insertion Site 15 January 2020